Boston Scientific Stock Forecast, Price & News

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BSX stock has increased by 10.9% and is now trading at $37.54.
View which stocks have been most impacted by COVID-19.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 3 hold ratings, 19 buy ratings and 3 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Boston Scientific.

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Boston Scientific.

Boston Scientific will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Boston Scientific Co. (NYSE:BSX) issued its quarterly earnings results on Wednesday, July, 29th. The medical equipment provider reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of ($0.04) by $0.12. The medical equipment provider earned $2 billion during the quarter, compared to the consensus estimate of $1.68 billion. Boston Scientific had a net margin of 39.18% and a return on equity of 12.86%. Boston Scientific's revenue for the quarter was down 23.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.39 EPS.
View Boston Scientific's earnings history.

25 analysts have issued 1 year target prices for Boston Scientific's shares. Their forecasts range from $25.00 to $58.00. On average, they anticipate Boston Scientific's share price to reach $45.00 in the next year. This suggests a possible upside of 19.9% from the stock's current price.
View analysts' price targets for Boston Scientific.

Boston Scientific saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 12,920,000 shares, a drop of 20.5% from the September 15th total of 16,250,000 shares. Based on an average daily volume of 7,350,000 shares, the short-interest ratio is currently 1.8 days.
View Boston Scientific's Short Interest.

Some companies that are related to Boston Scientific include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Steris (STE) and Varian Medical Systems (VAR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), The Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and salesforce.com (CRM).

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Boston Scientific's stock is owned by many different retail and institutional investors. Top institutional shareholders include Retirement Systems of Alabama (0.11%), Atalanta Sosnoff Capital LLC (0.10%), Factory Mutual Insurance Co. (0.09%), Assenagon Asset Management S.A. (0.06%), Gateway Investment Advisers LLC (0.06%) and Envestnet Asset Management Inc. (0.05%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Michael F Mahoney, Wendy Carruthers, Williamson Scott, Xin Warren Wang and Yoshiaki Fujimori.
View institutional ownership trends for Boston Scientific.

BSX stock was sold by a variety of institutional investors in the last quarter, including Robecosam AG, State of Alaska Department of Revenue, Redpoint Investment Management Pty Ltd, Atalanta Sosnoff Capital LLC, Gradient Investments LLC, Nisa Investment Advisors LLC, Nissay Asset Management Corp Japan ADV, and Pacer Advisors Inc.. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, and Wendy Carruthers.
View insider buying and selling activity for Boston Scientific.

BSX stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Nexus Investment Management ULC, Factory Mutual Insurance Co., TIAA FSB, CWM LLC, Rhenman & Partners Asset Management AB, Retirement Systems of Alabama, and DNB Asset Management AS.
View insider buying and selling activity for Boston Scientific.

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BSX stock can currently be purchased for approximately $37.54.

Boston Scientific has a market capitalization of $53.71 billion and generates $10.74 billion in revenue each year. The medical equipment provider earns $4.70 billion in net income (profit) each year or $1.58 on an earnings per share basis. Boston Scientific employs 36,000 workers across the globe.

The official website for Boston Scientific is www.bostonscientific.com.

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]